LENSAR Inc LNSR 深 滬
等待開盤 04-03 09:30:00 美东时间
6.06
+0.090
+1.51%
華盛通- 最 高6.14
- 今 開5.99
- 成交量 6.46万股
- 最 低 5.89
- 昨 收 5.97
- 總市值 7267.76万
- 52周最高 14.3099
- 市盈率 靜 --
- 換手率 0.54%
- 52周最低 5.35
- 委 比 -70.46%
- 總股本 1199.30万
- 歷史最高 17.31
- 量 比 0.34
- 振 幅 4.19%
- 歷史最低 1.80
- 每 手 1
- 風險率 1.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Lensar Earnings Call: Recurring Revenue Shines Amid Disruption
Lensar Inc (($LNSR)) has held its Q4 earnings call. Read on for the main highli...
04-02 08:21
Earnings Scheduled For March 31, 2026
Companies Reporting Before The Bell • Bitfarms (NASDAQ:BITF) is projected to re...
03-31 19:11
LENSAR Q4 EPS $(0.12) Misses $(0.07) Estimate, Sales $16.025M Miss $20.300M Estimate
LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.07) by 71.43 percent. This is a 92.55 percent increase over losses of $(1.61) per share from the same
03-31 18:19
Robotic cataract laser maker Lensar's Q4 revenue falls on system sales decline
Robotic cataract laser maker Lensar's Q4 revenue falls on system sales decline Overview U.S. robotic cataract laser maker's Q4 revenue fell 4% yr/yr, recurring revenue rose 17% Net loss for Q4 narrowed sharply compared to prior year, driven by warrant liability changes Company terminated Alcon merge
03-31 18:13
BRIEF-LENSAR Q4 Net Income USD -1.5 Million
BRIEF-LENSAR Q4 Net Income USD -1.5 Million Mar 31 (Reuters) - LENSAR Q4 EBITDA USD -400 thousand.
03-31 18:00
美股大行评级 | 超多下调！露露乐蒙、Oklo、腾讯音乐、Docusign、BOBS、Bicycle、Academy Sports等遭多家大行下调目标价
今日重点评级关注：花旗：维持Candel Therapeutics"买入"评级，目标价从22美元升至26美元；Chardan Capital：维持CervoMed"买入"评级，目标价从15美元升至21美元
03-19 14:31
BTIG Upgrades LENSAR to Buy, Announces $10 Price Target
BTIG analyst Ryan Zimmerman upgrades LENSAR (NASDAQ:LNSR) from Neutral to Buy and announces $10 price target.
03-18 17:50
U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks
U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks March 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Factset, Lensar and Starbucks on Wednesday. HIGHLIGHTS * Factset FDS.N : RBC cuts target price to $243 from $320 *
03-18 15:36
Why Playboy Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
Playboy (PLBY) shares rise in pre-market trading after reporting better-than-expected Q4 results. Other gainers include PTOR, LNAI, LIDR, ISPC, WNW, JVA, NUAI, XLO, and BW. Losers include PRSO, DFLI, LNSR, and MVST.
03-18 00:19
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review
Alcon cancels $356 million LENSAR merger due to regulatory delays and FTC opposition, adding pressure on shares.
03-17 21:04
